Company: TAK
Filing Date: 2025-10-30
Form Type: 6-K
Source: 0001395064-25-000154
Chunk: 39

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-10-30
Form: 6-K
Chunk 39
---
                   |     | June 12, 2030 - June 12, 2035 |

USD Unsecured Senior Notes:

| Issuance Date                   |     | July 2025                                   |
| Issue Amount (Principal Amount) |     | USD 2,400 million                           |
| Coupon Rate                     |     | 5.200% and 5.900% per annum                 |
| Issue Price                     |     | 99.644% and 99.734% of the principal amount |
| Maturity Date                   |     | July 7, 2035 and July 7, 2055               |

#### Redemption
(2) Loans

#### Repayment
*The execution date of "USD Bilateral Loans" was the original drawdown date, and the loans have been rolled over on a monthly basis.

<div align='center'>- 35 -</div>

Translation for reference purpose only

#### 10. Equity and Other Equity Items
(1) Issuance of shares and disposal of treasury shares

During the six-month period ended September 30, 2024, the Company issued 8,519 thousand shares of common stock and conducted the disposal of 7,327 thousand treasury shares under the LTIP for the Company Group employees overseas. The issuance of these shares resulted in an increase in share capital of JPY 18,064 million and share premium of JPY 18,064 million. The disposal of treasury shares resulted in a decrease in treasury shares of JPY 24,999 million.

During the six-month period ended September 30, 2025, the Company conducted the disposal of 17,271 thousand treasury shares under the LTIP for the Company Group employees overseas. The disposal of treasury shares resulted in a decrease in treasury shares of JPY 73,760 million.

The Company's treasury shares were converted into the Company’s American Depositary Shares and settled with employees.

(2) Acquisition of treasury share

During the six-month period ended September 30, 2025, Takeda acquired 11,824 thousand shares of its common stock for JPY 49,978 million in accordance with the resolution on the acquisition of its own shares at the Board of Directors Meeting held on January 30, 2025. Combined with its own shares acquired in the fiscal year ended March 31, 2025, Takeda acquired a total of 23,367 thousand shares of its common stock for JPY 99,956 million, and